Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways

Unlike other members of HSP70 family, GRP78 manifests multifaceted subcellular distribution and forms complex with different signals, resulting in its close correlation with various tumors. However, its expression profile and function in glioma remain less well defined. In this study, normal brain tissue and astrocytic tumor specimens were evaluated for GRP78 expression, which was shown to be up-regulated in astrocytoma compared with normal tissue, increased markedly as astrocytoma pathologic grade escalates, and can still be enhanced for disease recurrence. By employing Cox regression analyses, high GRP78 expression was correlated with a poorer outcome for recurrent glioblastoma patients. In addition, immunofluorescence microscopy detected cell surface positioning of GRP78 on human glioma cells. After transfection with siRNA or antibody ligation of surface GRP78, phosphorylation of Akt and ERK was attenuated. These findings indicate that GRP78 plays an important role in astrocytoma malignancy, whereas its cell surface localization may be attractive for clinical utilization.

Research Highlights▶ The expression of GRP78 is up-regulated for glioblastoma recurrence. ▶ High GRP78 expression is correlated with inferior outcome of recurrent glioblastoma. ▶ Positioning of GRP78 on glioma cell surface mediates intracellular signaling pathways. ▶ Cell surface GRP78 may be attractive approach for brain tumor treatment.